Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Isoxazole, 4-(chloromethyl)-5-methyl-3-phenyl- → {2-Methyl-3-[2-(5-methyl-3-phenyl-isoxazol-4-ylmethyl)-1,1-dioxo-2,3-dihydro-1h-1lambda6-benzo[d]isothiazol-3-yl]-indol-1-yl}-acetic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Isoxazole, 4-(chloromethyl)-5-methyl-3-phenyl- | HCID 11052826 | — |
| 반응물 | [3-(1,1-Dioxo-2,3-dihydro-1h-1lambda6-benzo[d]isothiazol-3-yl)-2-methyl-indol-1-yl]-acetic acid tert-butyl ester | HCID 67317115 | — |
| 생성물 | {2-Methyl-3-[2-(5-methyl-3-phenyl-isoxazol-4-ylmethyl)-1,1-dioxo-2,3-dihydro-1h-1lambda6-benzo[d]isothiazol-3-yl]-indol-1-yl}-acetic acid | HCID 11526569 | — |
반응 단계
The title compound was prepared by the method described for example 14 using the product from example 3, step c) and 4-chloromethyl-5-methyl-3-phenyl-isoxazole. MS: ESI (negative): 526 (M−H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07405215B2 |
| 출처 데이터셋 | uspto-grants-2008_07 |
| ORD ID | ord-71672a280e04472e97e892ae8c066505 |
| 출처 메모 | uspto-grants-2008_07 |